New Square Capital LLC Zoetis Inc. Transaction History

New Square Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$151.44 - $200.09 $53,004 - $70,031	350 New	350 $69,000
Q4 2022 Feb 06, 2023	BUY	$131.14 - $157.47 $786 - $944	6 New	6 $0
Q1 2022 May 10, 2022	SELL	$181.39 - $234.03 $9,069 - $11,701	-50 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$157.07 - $174.35 $7,853 - $8,717	50 New	50 $8,000
Q1 2020 May 08, 2020	SELL	$92.66 - $144.94 $26,871 - $42,032	-290 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$116.25 - $133.25 $33,712 - $38,642	290 New	290 $38,000
Q1 2019 Apr 25, 2019	SELL	$81.56 - $100.67 $204,307 - $252,178	-2,505 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$79.28 - $95.27 $198,596 - $238,651	2,505 New	2,505 $214,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.